Sichuan, China

Chengzhi Zhang


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: The Innovative Genius of Chengzhi Zhang

Introduction

Chengzhi Zhang, based in Sichuan, China, is a remarkable inventor known for his contributions to pharmaceutical advancements. With a focus on developing innovative compounds, Zhang has significantly impacted the field of medicine, particularly in treating adaptation diseases.

Latest Patents

Zhang's notable patent is for a "Halogen-substituted phenylate compound and applications thereof." This invention includes a compound of formula (I) or its optical isomers, and pharmaceutically acceptable salts, prodrugs, aquo-complexes, or non-aqueous-solvent complexes. The experimental results reveal that this compound demonstrates higher agonist activity towards THR-beta when compared to the control compound MGL-3196, along with a significantly improved selectivity for THR-beta over THR-alpha. This discovery opens new avenues for preparing THR-beta agonists and drugs aimed at treating various adaptation diseases, including dyslipidemia, hypercholesteremia, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease.

Career Highlights

Chengzhi Zhang is currently affiliated with Hinova Pharmaceuticals Inc., where he leverages his expertise to innovate and create effective pharmaceutical solutions. His dedication to research and development has made him a valuable asset to the company and the medical community.

Collaborations

Throughout his career, Zhang has collaborated with talented colleagues such as Wu Du and Yu Li. These partnerships have fostered a creative environment that encourages the exchange of ideas, leading to groundbreaking research and development of pharmaceutical compounds.

Conclusion

Chengzhi Zhang's contributions to the field of medicine, particularly with his patent on halogen-substituted phenylate compounds, demonstrate his commitment to innovation and improving health outcomes. His work at Hinova Pharmaceuticals Inc., coupled with valuable collaborations, continues to push the boundaries of what is possible in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…